Latest Als News

Redcastle Resources has reported a substantial 280% increase in its gold Mineral Resource Estimates at its Queen Alexandra and Redcastle Reef deposits, reaching a combined 42,000 ounces. The company also signed a strategic MoU with Terra Mining to accelerate mining operations with a low capital expenditure model.

Pioneer Lithium advances uranium exploration with promising high-grade assays at Skull Creek, while pausing lithium activities amid market downturn. A recent $320,000 capital raise supports ongoing uranium projects in the US and Namibia.

Metal Bank Limited reports significant resource upgrades at its Livingstone Gold Project and new graphite assay results at Millennium, while advancing copper exploration in the Middle East.

Connected Minerals Ltd has greenlit a Phase 2 drilling campaign at its Etango North-East Uranium Project in Namibia, following impressive Phase 1 results that revealed economic uranium grades in nearly all holes drilled.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

Peel Mining Limited has completed key drilling and commenced metallurgical testing at Wagga Tank, while advancing exploration and joint venture activities at Curnamona, maintaining a solid cash position of $1.4 million.

DataWorks Group reports a dramatic reduction in cash outflows and rising revenues, driven by strong contract execution and cost discipline, setting the stage for positive operating cash flow by December 2025.

Ausmon Resources reports promising assay results from its Limestone Coast Project, revealing significant rare earth element concentrations that bolster its exploration prospects in South Australia.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.

Solis Minerals has kicked off diamond drilling at its Chancho al Palo copper-gold project in Peru, revealing promising visual mineralisation including visible gold, while advancing permits and funding to support further exploration.

Peel Mining has completed key drilling and testwork at its Wagga Tank site while identifying promising gold targets at Nombinnie, setting the stage for expanded exploration.